Hong Qin
Corporate Officer/Principal chez Beijing Advaccine Biotechnology Co., Ltd.
Postes actifs de Hong Qin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Corporate Officer/Principal | 29/03/2021 | - |
Historique de carrière de Hong Qin
Anciens postes connus de Hong Qin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Teddy Clinical Research Laboratory Shanghai Ltd. | Directeur des opérations | 01/05/2017 | 01/03/2021 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Directeur des opérations | 01/10/2015 | 01/04/2017 |
| Shanghai Invitrogen Biotechnology Co. , Ltd. | Corporate Officer/Principal | 01/06/2011 | 01/04/2012 |
| Promega (Shanghai) Biological Products Ltd. | Directeur des opérations | 01/03/2010 | 01/04/2011 |
Formation de Hong Qin
| Texas Tech University | Graduate Degree |
| Nanjing Normal University | Graduate Degree |
Statistiques
Internationale
| Chine | 7 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Operating Officer | 3 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 4 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
| Teddy Clinical Research Laboratory Shanghai Ltd. | |
| Promega (Shanghai) Biological Products Ltd. | |
| Shanghai Invitrogen Biotechnology Co. , Ltd. |
